Basheer Abdulrahman

Favipiravir Efficacy And Safety For The Treatment Of Severe Coronavirus Disease 2019: A Retrospective Study.

A. Alharthy, A. Mady, W. Aletreby, 2022, Journal of Ayub Medical College, Abbottabad : JAMC.

Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series

Z. Memish, A. Alharthy, D. Karakitsos, 2020, Annals of Medicine and Surgery.

Emergence of Colistin Resistance against Multi-Drug Resistance Microorganisms and its Clinical Outcomes

S. Akhtar, A. Mady, Waqas Mahmood, 2021, Pakistan Journal of Medical and Health Sciences.

Comparison of severity of immunized versus non-immunized COVID-19 patients admitted to ICU: A prospective observational study

Z. Memish, A. Alharthy, A. Mady, 2021, Annals of Medicine and Surgery.

Tocilizumab Effect in COVID-19 Hospitalized Patients: A Systematic Review and Meta-Analysis of Randomized Control Trials

Z. Memish, A. Alharthy, D. Karakitsos, 2021, medRxiv.

“Ventilator-free days” composite outcome in patients with SARS-CoV-2 infection treated with tocilizumab: A retrospective competing risk analysis

A. Alharthy, A. Mady, S. Mumtaz, 2022, Heart & Lung.

Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis

A. Alharthy, D. Karakitsos, A. Mady, 2021, medRxiv.

Deferoxamine in the management of COVID-19 adult patients admitted to ICU: a prospective observational cohort study

Z. Memish, A. Mady, S. Mumtaz, 2023, Annals of medicine and surgery.